I am an expert in medicinal chemistry and currently lead compound management and biobank capabilities to support all stages of drug research and development with small molecules and human biological samples. I also lead the strategic development of Machine Learning for drug design and synthesis at AstraZeneca.
Before joining AstraZeneca in 2001, I undertook a PhD and post doc in organic chemistry. Over the past 18 years, I have developed a proven track record of delivering global scientific services and capabilities with transformational change in performance, operations and external scientific reputation, through collaboration on multidisciplinary research and project teams.
During my time at AstraZeneca, I have become an accomplished leader of people with a passion for innovation and developing a culture of improvement and adaptability.
I’m passionate about the development of automated technology innovation for compound design, synthesis and distribution. I believe advances in robotics and artificial intelligence offer genuine promise of improvement in drug discovery productivity.
Delivered technology innovations to enable commercial acoustic dispensing from storage tubes and a 10-fold reduction in sample requirements
Led the business transformation to a commercial, global IT platform for small molecule sample management